Enhancement of T lymphocyte differentiation in vitro by thymic extracts and purified polypeptides in severe combined immunodeficiency diseases. 1975

G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good

UI MeSH Term Description Entries
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007223 Infant A child between 1 and 23 months of age. Infants
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008934 Mitogens Substances that stimulate mitosis and lymphocyte transformation. They include not only substances associated with LECTINS, but also substances from streptococci (associated with streptolysin S) and from strains of alpha-toxin-producing staphylococci. (Stedman, 25th ed) Mitogen,Phytomitogen,Phytomitogens
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D006648 Histocompatibility The degree of antigenic similarity between the tissues of different individuals, which determines the acceptance or rejection of allografts. HLA Incompatibility,Histoincompatibility,Human Leukocyte Antigen Incompatibility,Immunocompatibility,Tissue Compatibility,Compatibility, Tissue,HLA Incompatibilities,Histocompatibilities,Histoincompatibilities,Immunocompatibilities,Incompatibility, HLA,Tissue Compatibilities
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
October 1981, Transplantation,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
December 1979, The Journal of clinical investigation,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
November 1974, Clinical immunology and immunopathology,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
March 1977, Proceedings of the National Academy of Sciences of the United States of America,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
December 1978, Clinical immunology and immunopathology,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
August 2021, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
January 1974, Transactions of the Association of American Physicians,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
December 1976, Lancet (London, England),
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
September 1980, The Journal of clinical investigation,
G S Incefy, and L Boumsell, and W Kagan, and G Goldstein, and M D Sousa, and E Smithwick, and R O'Reilly, and R A Good
December 1981, Molecular and cellular biochemistry,
Copied contents to your clipboard!